Physician profile
Robert Boatwright Harris
NPI 1215011846
$10,558.04
in general payments reported to CMS, 2019-2025
13 companies · $9,977 in 2025
The $9,977 reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.68 · 2020: $25.34 · 2021: $430 · 2022: $18.16 · 2023: $26.97 · 2024: $45.90 · 2025: $9,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,151 · Travel and Lodging: $2,653 · Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,151.45 |
| Travel and Lodging | $2,653.42 |
| Food and Beverage | $244.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,836.63 | 2024-2025 | |
| Stryker Corporation | $411.91 | 2021 | |
| Davol INC. | $143.79 | 2021-2025 | Phasix Mesh |
| Medtronic, INC. | $23.32 | 2025 | Progrip |
| Boston Scientific Corporation | $23.10 | 2025 | Axonics |
| Smith+Nephew, INC. | $22.81 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $18.16 | 2022 | |
| Inari Medical, INC. | $14.14 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medela LLC | $13.95 | 2020 | |
| Becton, Dickinson and Company | $13.78 | 2023 | Bd Onclarity |
| Axonics, INC. | $13.19 | 2023 | Axonics |
| Lemaitre Vascular, INC. | $12.44 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.